Advancements in Purine Analogs for AML Treatment

This chapter discusses the development of purine analogs like fludarabine, cladribine, and clofarabine in treating acute myeloid leukemia (AML), highlighting historical progress and associated challenges. It also examines the importance of FLAG therapy and the synergistic effects of combining purine analogs with cytarabine, particularly for elderly patients.